Project Grant R01CA290828
Award Date
9/12/24
Completion Date
8/31/29
Dollars Obligated
$557K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Columbia, SC 29208, USA
Similar Awards
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will support a hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The $619,175 award, effective December 1, 2024, will be used by the Medical University of South Carolina to directly compare rates of switching from cigarettes to e-cigarettes...
The National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research grant program (CFDA 93.393), awarded a $407,581 project grant to Texas Christian University (TCU) to conduct a longitudinal study examining the relationship between social media engagement and electronic nicotine delivery systems (ENDS) use among young adults. The 3-year project aims to identify the cognitive mediators and intra- and inter-personal moderators of the associations between social media...
This Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a research project to identify key features of e-cigarette-related social media posts that are associated with high user engagement. The goal is to provide guidance for designing effective vaping prevention messages for future public health campaigns to help communicate the risks of e-cigarette use and prevent youth and young adult initiation...
This $310,319 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will support the University of Louisville in conducting formative research to develop a motivation-based adolescent vaping typology to inform the development of tailored cognitive behavioral e-cigarette cessation interventions. The key objectives are to: 1) identify different types of adolescent e-cigarette users based on their motivations for use, 2)...
This Project Grant award, totaling $3,257,011, was provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund a hybrid effectiveness-implementation randomized controlled trial to evaluate the impact of switching to electronic nicotine delivery systems (ENDS) compared to nicotine replacement therapy (NRT) for smoking cessation among clients enrolled in substance use disorder (SUD) treatment programs in...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the Regents of the University of California, San Francisco will provide $692,872 to develop and evaluate a scalable social media-based vaping cessation program for adolescents. The project, titled "Social Media Support Groups for Adolescent Vaping Cessation," will adapt the existing "Quit the Hit" program into a toolkit (QTHT) that can be implemented...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) will provide $594,099 to Brown University from December 1, 2024 to November 30, 2028 to characterize behavioral economic mechanisms underlying dual use of marijuana and tobacco among young adults. The research will utilize novel laboratory-based measures including cross-price elasticity of demand and cross-cue reactivity to understand how changes in availability and environmental cues...
The federal Project Grant award R01CA298165 was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The $625,201 award will fund a 5-year randomized factorial trial to evaluate the combined impact of varenicline, nicotine lozenges, and a smartphone-based medication adherence intervention on smoking cessation outcomes among 496 adult daily smokers. The study aims to improve smoking cessation treatment and reduce cancer risk. A...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $226,504.00 to George Washington University to conduct research examining tobacco use behaviors and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The study aims to test the hypothesis that individuals with intersecting minority identities (e.g., racial/ethnic minorities, sexual/gender minorities, low socioeconomic...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...